Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy - PubMed (original) (raw)
. 2007 Jan;148(1):452-60.
doi: 10.1210/en.2006-0539. Epub 2006 Oct 12.
Affiliations
- PMID: 17038559
- DOI: 10.1210/en.2006-0539
Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy
H Gilson et al. Endocrinology. 2007 Jan.
Abstract
Glucocorticoids mediate muscle atrophy in many catabolic states. Myostatin expression, a negative regulator of muscle growth, is increased by glucocorticoids and myostatin overexpression is associated with lower muscle mass. This suggests that myostatin is required for the catabolic effects of glucocorticoids. We therefore investigated whether myostatin gene disruption could prevent muscle atrophy caused by glucocorticoids. Male myostatin knockout (KO) and wild-type mice were subjected to dexamethasone treatment (1 mg/kg.d for 10 d or 5 mg/kg.d for 4 d). In wild-type mice, daily administration of low-dose dexamethasone for 10 d resulted in muscle atrophy (tibialis anterior: -15%; gastrocnemius: -13%; P < 0.01) due to 15% decrease in the muscle fiber cross-sectional area (1621 +/- 31 vs. 1918 +/- 64 microm(2), P < 0.01). In KO mice, there was no reduction of muscle mass nor fiber cross-sectional area after dexamethasone treatment. Muscle atrophy after 4 d of high-dose dexamethasone was associated with increased mRNA of enzymes involved in proteolytic pathways (atrogin-1, muscle ring finger 1, and cathepsin L) and increased chymotrypsin-like proteasomal activity. In contrast, the mRNA of these enzymes and the proteasomal activity were not significantly affected by dexamethasone in KO mice. Muscle IGF-I mRNA was paradoxically decreased in KO mice (-35%, P < 0.05); this was associated with a potentially compensatory increase of IGF-II expression in both saline and dexamethasone-treated KO mice (2-fold, P < 0.01). In conclusion, our results show that myostatin deletion prevents muscle atrophy in glucocorticoid-treated mice, by blunting the glucocorticoid-induced enhanced proteolysis, and suggest an important role of myostatin in muscle atrophy caused by glucocorticoids.
Similar articles
- Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats.
Schakman O, Gilson H, de Coninck V, Lause P, Verniers J, Havaux X, Ketelslegers JM, Thissen JP. Schakman O, et al. Endocrinology. 2005 Apr;146(4):1789-97. doi: 10.1210/en.2004-1594. Epub 2005 Jan 20. Endocrinology. 2005. PMID: 15661854 - The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression.
Salehian B, Mahabadi V, Bilas J, Taylor WE, Ma K. Salehian B, et al. Metabolism. 2006 Sep;55(9):1239-47. doi: 10.1016/j.metabol.2006.05.009. Metabolism. 2006. PMID: 16919545 - Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression.
Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, Salehian B. Ma K, et al. Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E363-71. doi: 10.1152/ajpendo.00487.2002. Epub 2003 Apr 29. Am J Physiol Endocrinol Metab. 2003. PMID: 12721153 - Glucocorticoid-induced skeletal muscle atrophy.
Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP. Schakman O, et al. Int J Biochem Cell Biol. 2013 Oct;45(10):2163-72. doi: 10.1016/j.biocel.2013.05.036. Epub 2013 Jun 24. Int J Biochem Cell Biol. 2013. PMID: 23806868 Review. - Mechanisms of glucocorticoid-induced myopathy.
Schakman O, Gilson H, Thissen JP. Schakman O, et al. J Endocrinol. 2008 Apr;197(1):1-10. doi: 10.1677/JOE-07-0606. J Endocrinol. 2008. PMID: 18372227 Review.
Cited by
- Myostatin and the Heart.
Knapp M, Supruniuk E, Górski J. Knapp M, et al. Biomolecules. 2023 Dec 12;13(12):1777. doi: 10.3390/biom13121777. Biomolecules. 2023. PMID: 38136649 Free PMC article. Review. - Inflammation: Roles in Skeletal Muscle Atrophy.
Ji Y, Li M, Chang M, Liu R, Qiu J, Wang K, Deng C, Shen Y, Zhu J, Wang W, Xu L, Sun H. Ji Y, et al. Antioxidants (Basel). 2022 Aug 29;11(9):1686. doi: 10.3390/antiox11091686. Antioxidants (Basel). 2022. PMID: 36139760 Free PMC article. Review. - Myostatin regulates pituitary development and hepatic IGF1.
Czaja W, Nakamura YK, Li N, Eldridge JA, DeAvila DM, Thompson TB, Rodgers BD. Czaja W, et al. Am J Physiol Endocrinol Metab. 2019 Jun 1;316(6):E1036-E1049. doi: 10.1152/ajpendo.00001.2019. Epub 2019 Mar 19. Am J Physiol Endocrinol Metab. 2019. PMID: 30888862 Free PMC article. - Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways.
Rodriguez J, Vernus B, Chelh I, Cassar-Malek I, Gabillard JC, Hadj Sassi A, Seiliez I, Picard B, Bonnieu A. Rodriguez J, et al. Cell Mol Life Sci. 2014 Nov;71(22):4361-71. doi: 10.1007/s00018-014-1689-x. Epub 2014 Jul 31. Cell Mol Life Sci. 2014. PMID: 25080109 Free PMC article. Review. - mRNA-seq reveals skeletal muscle atrophy in response to handling stress in a marine teleost, the red cusk-eel (Genypterus chilensis).
Aedo JE, Maldonado J, Aballai V, Estrada JM, Bastias-Molina M, Meneses C, Gallardo-Escarate C, Silva H, Molina A, Valdés JA. Aedo JE, et al. BMC Genomics. 2015 Dec 1;16:1024. doi: 10.1186/s12864-015-2232-7. BMC Genomics. 2015. PMID: 26626593 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials